Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 4
2014 9
2015 5
2016 9
2017 10
2018 8
2019 7
2020 13
2021 33
2022 35
2023 20
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab in enteropathic arthritis.
Ulusoy BÖ, Erden A, Güven SC, Armağan B, Yürekli ÖT, Özin YÖ, Omma A, Küçükşahin O. Ulusoy BÖ, et al. Among authors: kucuksahin o. Immunotherapy. 2023 Jun;15(8):583-592. doi: 10.2217/imt-2022-0197. Epub 2023 Apr 5. Immunotherapy. 2023. PMID: 37020400
Response to the letter to the editor.
Guner R, Hasanoglu I, Kayaaslan B, Aypak A, Akinci E, Bodur H, Eser F, Kaya Kalem A, Kucuksahin O, Ates I, Bastug A, Tezer Tekce Y, Bilgic Z, Gursoy FM, Akca HN, Izdes S, Erdem D, Asfuroglu E, Hezer H, Kilic H, Civak M, Aydogan S, Buzgan T. Guner R, et al. Among authors: kucuksahin o. J Infect Public Health. 2022 Jan;15(1):65-67. doi: 10.1016/j.jiph.2021.12.007. Epub 2021 Dec 11. J Infect Public Health. 2022. PMID: 34915424 Free PMC article. No abstract available.
Tofacitinib experience in patients with enteropathic arthritis.
Dağlı PA, Erden A, Güven SC, Armağan B, Yürekli ÖT, Özin YÖ, Omma A, Küçükşahin O. Dağlı PA, et al. Among authors: kucuksahin o. Immunotherapy. 2023 Jun;15(8):619-626. doi: 10.2217/imt-2022-0110. Epub 2023 Apr 3. Immunotherapy. 2023. PMID: 37009645 Review.
The association of anti-CD74 antibody with spondyloarthropathies.
Çolak S, Turgay TM, Küçükşahin O, Duman MT, Çetinkaya H, Toruner M. Çolak S, et al. Among authors: kucuksahin o. Eur J Rheumatol. 2021 Oct;8(4):207-210. doi: 10.5152/eurjrheum.2021.20090. Eur J Rheumatol. 2021. PMID: 34554908 Free PMC article.
Reducing length of hospital stay with colchicine.
Karakaş Ö, Erden A, Güven SC, Armağan B, Sahiner ES, Kurtipek AC, Inan O, Gemcioglu E, Ateş İ, Omma A, Küçüksahin O. Karakaş Ö, et al. Among authors: kucuksahin o. J Infect Dev Ctries. 2022 Jan 31;16(1):57-62. doi: 10.3855/jidc.14924. J Infect Dev Ctries. 2022. PMID: 35192522 Free article.
Colchicine Intolerance: Does the Pharmaceutical Preparation Matter?
İlgen U, Emmungil H, Küçükşahin O. İlgen U, et al. Among authors: kucuksahin o. Balkan Med J. 2021 Jul;38(4):257-258. doi: 10.5152/balkanmedj.2021.21128. Balkan Med J. 2021. PMID: 34155983 Free PMC article. No abstract available.
Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
Kalyoncu U, Bilgin E, Erden A, Satış H, Tufan A, Tekgöz E, Ateş A, Coşkun BN, Yağız B, Küçükşahin O, Yazısız V, Kimyon G, Bes C, Başıbüyük CS, Alkan S, Cesur TY, Ertenli İ, Kiraz S. Kalyoncu U, et al. Among authors: kucuksahin o. Clin Exp Rheumatol. 2022 Nov;40(11):2071-2077. doi: 10.55563/clinexprheumatol/9h6dtb. Epub 2022 Jan 25. Clin Exp Rheumatol. 2022. PMID: 35084323 Free article.
130 results